Cardiff Oncology, Inc.CRDFNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-37.77M
↓ 51% below average
Average (9y)
$-24.99M
Historical baseline
Range
High:$-13.21M
Low:$-37.77M
CAGR
+5.0%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-37.77M | -20.0% |
| 2023 | $-31.47M | +9.3% |
| 2022 | $-34.71M | -49.3% |
| 2021 | $-23.25M | -40.7% |
| 2020 | $-16.53M | -23.9% |
| 2019 | $-13.34M | -1.0% |
| 2018 | $-13.21M | +43.5% |
| 2017 | $-23.38M | +26.6% |
| 2016 | $-31.86M | -30.8% |
| 2015 | $-24.36M | - |